Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Gastroenterology. 2016 Jan 9;150(4):911–917. doi: 10.1053/j.gastro.2015.12.040

Table 2. Procedural Characteristics.

Characteristic Indomethacin (n=223) Placebo (n=226) P value

Sphincter Manipulation
 Difficult Cannulation (>8 attempts) – no. (%) 46 (20.6) 42 (18.4) 0.64
 Precut Biliary Sphincterotomy 11 (4.9) 16 (7.0) 0.43
 Therapeutic Biliary Sphincterotomy – no. (%) 106 (46.9) 114 (50.9) 0.57
 Therapeutic Pancreatic Sphincterotomy – no. (%) 12 (5.4) 5 (2.2) 0.08
 Minor Duct Sphincterotomy – no. (%) 5 (2.2) 4 (1.8) 0.75
 Balloon Dilation of Biliary Sphincter – no. (%) 21 (9.4) 20 (8.8) 0.87
Pancreatic Duct Manipulation
 Wire Cannulation of Pancreatic Duct – no. (%) 90 (40.3) 89 (31.4) 0.85
 Pancreatography – no. (%) 50 (22.4) 49 (21.7) 0.97
 Pancreatic Acinarization – no. (%) 5 (2.2) 4 (1.8) 0.75
Stent Placement
 Biliary Stent Placement – no. (%) 89 (39.9) 84 (37.2) 0.56
 Pancreatic Stent Placement – no. (%) 36 (16.1) 35 (15.5) 0.90
Other Interventions
 Trainee Involvement in ERCP – no. (%) 152 (68.2) 168 (74.3) 0.18
 Concomittant EUS/FNA – no. (%) 41 (18.4) 40 (17.7) 0.90
 Periprocedural Fluid Volume - ml 705 703 0.95